Log In
Print
BCIQ
Print
Print this Print this
 

Remodulin, Treprost, treprostinil (MD-0701)

Also known as: formerly Uniprost, UT-15

  Manage Alerts
Collapse Summary General Information
Company United Therapeutics Corp.
DescriptionSynthetic long-acting stable prostacyclin analog
Molecular Target Not available
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat primary pulmonary hypertension (PPH); Treat pulmonary arterial hypertension (PAH); Treat pulmonary hypertension (PH)
Regulatory Designation

Partner

Bioprojet Pharma S.a.r.l.; Mochida Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today